The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

It’s the latest in a string of setbacks for Novo this morning. Results from a study of a higher dose of Wegovy disappointed ...

It’s the latest in a string of setbacks for Novo this morning. Results from a study of a higher dose of Wegovy disappointed ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications ... “Some folks have to ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

WASHINGTON (AP) — Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.